The use of preliminary scientific evidence in public health: a case study of XMRV
- PMID: 24714396
- PMCID: PMC3979645
- DOI: 10.1371/journal.pmed.1001623
The use of preliminary scientific evidence in public health: a case study of XMRV
Abstract
Kumanan Wilson and colleagues explain how the rapid response to XMRV as a novel pathogen has highlighted some challenges pertaining to policy-making and editorial responsibilities. The impact on policy and the propagation of the initial scientific information may not cease if the evidence is disproven and retracted from the peer-reviewed literature, which creates a challenge for regulators and scientific journals. Please see later in the article for the Editors' Summary.
Conflict of interest statement
KW is an unpaid member of Canadian Blood Services Scientific Advisory Board. The authors have no other conflicts of interest to report.
Figures
References
-
- Kakisi OK, Robinson MJ, Tettmar KI, Tedder RS (2013) The rise and fall of XMRV. Transfus Med 23: 142–151. - PubMed
-
- van Kuppeveld FJ, van der Meer JW (2012) XMRV and CFS–the sad end of a story. Lancet 379: e27–28. - PubMed
-
- Karafin MS, Stramer SL (2012) The scientific method at work: xenotropic murine leukemia virus-related virus is neither a cause of chronic fatigue syndrome nor a threat to the blood supply. Transfusion 52: 222–225. - PubMed
-
- Dodd RY (2011) Chronic fatigue syndrome, XMRV and blood safety. Future Microbiol 6: 385–389. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials